The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 19, 2018

Filed:

Dec. 16, 2014
Applicants:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Harry Chobanian, Kenilworth, NJ (US);

Barbara Pio, Kenilworth, NJ (US);

Yan Guo, Kenilworth, NJ (US);

Fa-xiang Ding, Kenilworth, NJ (US);

Shuzhi Dong, Kenilworth, NJ (US);

Shawn P. Walsh, Kenilworth, NJ (US);

Jinlong Jiang, Kenilworth, NJ (US);

Dooseop Kim, Seoul, KR;

Inventors:

Harry Chobanian, Kenilworth, NJ (US);

Barbara Pio, Kenilworth, NJ (US);

Yan Guo, Kenilworth, NJ (US);

Fa-Xiang Ding, Kenilworth, NJ (US);

Shuzhi Dong, Kenilworth, NJ (US);

Shawn P. Walsh, Kenilworth, NJ (US);

Jinlong Jiang, Kenilworth, NJ (US);

Dooseop Kim, Seoul, KR;

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4355 (2006.01); A61K 31/437 (2006.01); A61K 31/4985 (2006.01); A61K 31/519 (2006.01); A61K 31/55 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); A61K 31/401 (2006.01); A61K 31/4178 (2006.01); A61K 31/424 (2006.01); A61K 31/4422 (2006.01); A61K 31/496 (2006.01); A61K 31/4965 (2006.01); A61K 31/585 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/401 (2013.01); A61K 31/4178 (2013.01); A61K 31/424 (2013.01); A61K 31/437 (2013.01); A61K 31/4422 (2013.01); A61K 31/496 (2013.01); A61K 31/4965 (2013.01); A61K 31/4985 (2013.01); A61K 31/519 (2013.01); A61K 31/55 (2013.01); A61K 31/585 (2013.01); A61K 45/06 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01);
Abstract

The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.


Find Patent Forward Citations

Loading…